Aurinia Pharmaceuticals (IKAP) Q2 2026 Earnings Report
DE:IKAP Q2 2026 EPS Results
- Actual EPS
- EUR 0.25
- Consensus EPS
- EUR 0.21
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- EUR 0.14
DE:IKAP Q2 2026 Revenue Results
- Actual Revenue
- EUR 74.41M
- Expected Revenue
- EUR 71.93M
- Beat/Miss
- Beat by +EUR 2.48M
- YoY Revenue Growth
- +18.87%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- Before Open
- Conference Call
- Thursday, August 6, 2026
DE:IKAP Upcoming Earnings
Aurinia Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IKAP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.19- | 1.37 | ― | ― |
| Oct 30, 2026 | 2026 (Q3) | 0.200.21 | 0.21 | 0.00% (+0.00) | |
| Aug 06, 2026 | 2026 (Q2) | 0.210.25 | 0.14 | 75.00% (+0.11) | |
| May 07, 2026 | 2026 (Q1) | 0.170.22 | 0.14 | 56.25% (+0.08) | |
| Feb 26, 2026 | 2025 (Q4) | 0.191.37 | 0.01 | 15200.00% (+1.36) | |
| Nov 04, 2025 | 2025 (Q3) | 0.140.21 | 0.09 | 130.00% (+0.12) | |
| Jul 31, 2025 | 2025 (Q2) | 0.130.14 | 0.01 | 1500.00% (+0.13) | |
| May 12, 2025 | 2025 (Q1) | 0.090.14 | -0.06 | 328.57% (+0.21) | |
| Feb 27, 2025 | 2024 (Q4) | -0.010.01 | -0.17 | 105.26% (+0.18) | |
| Nov 07, 2024 | 2024 (Q3) | 0.010.09 | -0.08 | 211.11% (+0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
